Literature DB >> 9508324

Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases.

H Vahaboglu1, R Ozturk, H Akbal, S Saribas, O Tansel, F Coşkunkan.   

Abstract

A practical approach to detect and identify ceftazidime-hydrolyzing extended-spectrum mutants of OXA-10 beta-lactamase is presented. Large numbers of bacteria were screened by colony hybridization, a 720-bp part of blaOXA was amplified by PCR from the hybridization-positive isolates, and the products were digested by PvuII and HaeIII.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9508324      PMCID： PMC104637          DOI： 10.1128/JCM.36.3.827-829.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.

Authors:  R E Hancock; W A Woodruff
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

2.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

3.  Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.

Authors:  H Vahaboglu; R Oztürk; G Aygün; F Coşkunkan; A Yaman; A Kaygusuz; H Leblebicioglu; I Balik; K Aydin; M Otkun
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

4.  Characterization of multiple-antibiotic-resistant Salmonella typhimurium stains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone.

Authors:  H Vahaboglu; S Dodanli; C Eroglu; R Oztürk; G Soyletir; I Yildirim; V Avkan
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

Authors:  L M Hall; D M Livermore; D Gur; M Akova; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

6.  Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.

Authors:  H Y Chen; M Yuan; D M Livermore
Journal:  J Med Microbiol       Date:  1995-10       Impact factor: 2.472

7.  OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

Authors:  F Danel; L M Hall; D Gur; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  7 in total
  9 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.

Authors:  A Gündoğdu; Y B Long; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-24       Impact factor: 3.267

3.  Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.

Authors:  Jing-Jou Yan; Po-Ren Hsueh; Jang-Jih Lu; Feng-Yee Chang; Jainn-Ming Shyr; Jen-Hsien Wan; Yung-Ching Liu; Yin-Ching Chuang; Yi-Chueh Yang; Shih-Ming Tsao; Hsiu-Hung Wu; Li-Shin Wang; Tsuey-Pin Lin; Hsiu-Mei Wu; Hung-Mo Chen; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.

Authors:  Elisabetta Nucleo; Laura Steffanoni; Giulia Fugazza; Roberta Migliavacca; Ernesto Giacobone; Antonella Navarra; Laura Pagani; Paolo Landini
Journal:  BMC Microbiol       Date:  2009-12-22       Impact factor: 3.605

5.  OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.

Authors:  L Poirel; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

6.  Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.

Authors:  D Girlich; L Poirel; A Leelaporn; A Karim; C Tribuddharat; M Fennewald; P Nordmann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa.

Authors:  Véronique Dubois; Laurent Poirel; Caroline Marie; Corinne Arpin; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa.

Authors:  Frédéric Bert; Zahia Ould-Hocine; Manette Juvin; Véronique Dubois; Véronique Loncle-Provot; Valérie Lefranc; Claudine Quentin; Nicole Lambert; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).

Authors:  Jwu-Ching Shu; Ju-Hsin Chia; Leung-Kei Siu; An-Jing Kuo; Shu-Huan Huang; Lin-Hui Su; Tsu-Lan Wu
Journal:  Int J Antimicrob Agents       Date:  2011-11-10       Impact factor: 5.283
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.